Waters, Beckman Coulter, Applied Biosystems, ProtiVeris, Ciphergen, Cambridge Antibody Technology, Dyax, Cellzome, Lynx, Deltagen, UC Riverside | GenomeWeb

Waters Reports Increased Earnings for a challenging 2002

Waters reported increased fourth-quarter and year-end earnings last week. The company’s fourth quarter earnings totaled $40.2 million, or $0.31 per diluted share, on sales of $256.4 million, compared to a loss of $1.4 million or a penny per share on sales of $248.7 million for the same period last year. For 2002, the company earned $147.7 million on sales of $890 million, compared to $114.5 million on sales of $859.2 million in 2001.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.